Skip to main content
ORINF logo

Orion Oyj (ORINF) Stock Price & Analysis

Orion Oyj (ORINF) — price $115.60 (0.00%), as of the Nov 18, 2026 trading session; market cap $16.2B.

Educational signal · not a buy or sell recommendation · How to read this

$115.60 $0.00 (0.00%) Market Cap $16.2B

Orion Oyj · ORINF

Orion Oyj is a Finnish pharmaceutical company developing, manufacturing, and marketing human and veterinary drugs, active pharmaceutical ingredients, and contract manufacturing services globally. The company focuses on therapeutic areas including oncology, Parkinson's disease, respiratory conditions, and intensive care, serving healthcare providers and pet owners.

Price as of Nov 18, 2026

Key Statistics

No MoonshotScore yet: we have not published a score for this company.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • BIIB · Biogen Inc. · 37 /100
  • GRFS · Grifols, S.A. · 60 /100
  • OGN · Organon & Co. · 37 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$115.60
Change on the day0.00%
52-week range$78.95 – $115.60
Market capitalisation$16.2B
Price / earnings (trailing)21.71
Shares traded on the day200

Price & events

Other perspectives

Council score for Orion Oyj (ORINF): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

4 lenses, 4 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Favorable read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Strong
Margin of Safety Fairly Valued
Profit Margin Strong
Revenue Growth Strong
Debt/Equity Strong
ROE Strong
Gross Margin Strong

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 18, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Orion Oyj (ORINF), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Orion Oyj (ORINF) is the company analyzed here. It employs 4,029 people and is led by Aino Anna Liisa Hurme. The market values it at $16.2B.

3 · Financial strengths and risks

What are the financial strengths and risks for Orion Oyj (ORINF)?

Short answer · as of

The distress and quality screens read Altman Z 17.76 · Piotroski F 7. Trailing ratios: ROE 54.5% · ROA 27.4% · current ratio 2.72.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held ORINF in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported ORINF in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Orion Oyj (ORINF)?

Read these with our analysis →

Investor Questions: ORINF Stock

These answers are editorial: 1 of these 8 answers is drawn from the ORINF research dossier (written Jun 14, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.

Is ORINF a good stock to buy?

Stock Expert AI does not rate ORINF buy, sell or hold. Orion Oyj has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the ORINF stock price today?

The last price recorded for Orion Oyj (ORINF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What are the specific risks associated with investing in Orion Oyj (ORINF)?

Investing in Orion Oyj (ORINF) carries several specific risks. A primary concern is the inherent uncertainty of pharmaceutical R&D, where drug development failures or delays in regulatory approvals can significantly impact future revenue and profitability.

What are the key factors to evaluate for ORINF?

Evaluate ORINF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. The ongoing need for effective cancer treatments ensures a sustained demand, offering a long-term growth trajectory for this key product. Not financial advice.

How frequently does ORINF data refresh on this page?

ORINF's price is the last quote we recorded, from the Nov 18, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven ORINF's recent stock price performance?

Orion Oyj (ORINF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio across human and veterinary pharmaceuticals, APIs, and contract manufacturing. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ORINF overvalued or undervalued right now?

The trailing P/E of Orion Oyj (ORINF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research ORINF before investing?

Before investing in Orion Oyj (ORINF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 11 figures on this page — 7 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.